At 3 years , 178 ( 84 % ) of 213 participants in the imiquimod group were treated successfully compared with 185 ( 98 % ) of 188 participants in the surgery group ( RR 0.84 , 98 % CI 0.78-0 .91 ; p < 0.0001 ) .